GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma

NCT07670260 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Large B-cell Lymphoma

Interventions

BIOLOGICAL: GoFast CD19 CAR T Cells

Sponsor

Chinese PLA General Hospital